뒤로
Alphamab Oncology(09966.HK) 가격
09966.HK 주가 차트
ALPHAMAB-B (09966.HK)
Alphamab Oncology
HK$9.91
-2.84%
$-0.28
정규장: Jan 19, 13:33:45 HKT
주요 통계
이전 종가
$10.2
시가
$10.2
일일 범위
$9.76 - $10.2
52주 범위
$3.05 - $15.75
거래량
1.0M
평균 거래량
2.5M
EPS(TTM)
0.27
배당수익률
--
시가총액
$9.6B
ALPHAMAB-B란 무엇인가요?
Alphamab Oncology is an investment holding company. The company is headquartered in Suzhou, Jiangsu and currently employs 484 full-time employees. The company went IPO on 2019-12-12. The Company’s in-house pipeline consists of antibody-drug conjugates (ADCs), monoclonal antibodies and bispecific antibodies in staggered development status in oncology. The Company’s product pipeline includes KN046 (PD-L1/CTLA-4 bispecific antibody), KN026 (HER2/HER2 bispecific antibody), KN035 (SubQ PD-L1), JSKN003 (HER2 biparatopic ADC), JSKN016(HER3/TROP2 bispecific antibody ADC), JSKN033(subcutaneous co-formulation of JSKN003 and KN035), used for indications such as 1L sq NSCLC, 1L HER2+ BC, 1L biliary track cancer, advanced solid tumors, HER2-expressing solid tumors and others.
